Soleus Capital Management, L.P.

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1802630 GREENWICH, CT

Position in EWTX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$18,319,620

-$27,352,702 QoQ

Shares Held

450,889

-68.9% QoQ

Ownership

0.415%

of shares outstanding

% of Portfolio

0.63%

of 13F equity value

Holder Rank

#41

of 223 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. EWTX ranks #27 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	939,254	$349,092,534
2	CELC	Celcuity Inc.	1,704,318	$178,305,749
3	TGTX	Tg Therapeutics, Inc.	2,927,895	$160,858,551
4	RIGL	Rigel Pharmaceuticals Inc	1,843,504	$72,117,876
5	VCEL	Vericel Corp	1,459,152	$64,917,672
6	PRAX	Praxis Precision Medicines, Inc.	177,517	$59,430,916
7	GERN	Geron Corp	42,808,659	$54,795,083
8	ERAS	Erasca, Inc.	2,700,000	$49,464,000

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,319,620	450,889	-68.9%	Shares	Sole	2026-08-11
2026-03-31	$45,672,322	1,449,915	+59.3%	Shares	Sole	2026-05-14
2025-12-31	$22,581,650	910,000	+1089.7%	Shares	Sole	2026-02-12
2025-06-30	$1,002,823	76,493	+5.8%	Shares	Sole	2025-08-15
2025-03-31	$1,590,600	72,300	-60.6%	Shares	Sole	2025-05-15
2024-12-31	$4,894,110	183,300	+485.6%	Shares	Sole	2025-02-14
2021-09-30	$519,580	31,300	0.0%	Shares	Sole	2021-11-15
2021-06-30	$667,629	31,300	-68.7%	Shares	Sole	2021-08-16
2021-03-31	$3,250,000	100,000	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.